According to a review published in Natures Signal Transduction and Targeted Therapy, the global peptide therapeutics market grew from $41.44 billion in 2023 to $45.66 billion in 2024, a compound annual growth rate of over 10%, reflecting the rapid expansion of peptide research and clinical applications
Mechanistically, GSH depletion and the decrease in nuclear factor erythroid 2-related factor 2 (Nrf2), glutathione peroxidase 4 (GPx4), and xCT cystineglutamate antiporter (the main component is SLC7A11) are involved in atorvastatin-induced muscular cell ferroptosis and damage
non-NMDA) subtype of excitatory amino acid (glutamate) receptor
For weightloss peptides, thoughtful nutrition prevents excessive muscle loss
Use as an active pharmaceutical ingredient (API) in compounding, manufacturing, or drug formulation
Schedule a Miami consultation to learn how regenerative medicine for ankle arthritis may fit into a personalized plan for chronic ankle pain